دورية أكاديمية
Interim FDG-PET/CT for therapy monitoring and prognostication in Hodgkin’s Lymphoma
العنوان: | Interim FDG-PET/CT for therapy monitoring and prognostication in Hodgkin’s Lymphoma |
---|---|
المؤلفون: | Akram Al-Ibraheem, Farah Anwer, Malik E. Juweid, Qaid Ahmed Shagera, Aysar N. Khalaf, Shahed Obeidat, Areen Mansour, Mohammad Ma’koseh, Khalid Halahleh, Imad Jaradat, Nidal Almasri, Asem Mansour |
المصدر: | Scientific Reports, Vol 12, Iss 1, Pp 1-8 (2022) |
بيانات النشر: | Nature Portfolio, 2022. |
سنة النشر: | 2022 |
المجموعة: | LCC:Medicine LCC:Science |
مصطلحات موضوعية: | Medicine, Science |
الوصف: | Abstract The aim of the study was to assess the predictive value of interim FDG-PET/CT (iPET) in patients with Hodgkin’s lymphoma (HL) treated with Adriamycin, bleomycin, vinblastine and dacarbazine (ABVD) chemotherapy. A total of 245 consecutive patients with de novo HL between 12/2013 and 12/2017 were evaluated retrospectively. All patients were treated with upfront ABVD, performed PET/CT scans at baseline, after 2 cycles (interim PET, iPET2) or 4 cycles (iPET4) and at the end of therapy, and followed up for at least 6 months after therapy. The response status on iPET was defined according to the standard five-point Deauville scores (DS) as follows: complete metabolic response (CMR, DS 1–3) and non-complete metabolic response (nCMR) (DS 4 and 5). End-of-treatment (EoT) response was assessed by FDG-PET/CT and if needed biopsy confirmation of PET-positive findings. The association between iPET and EoT response was investigated using logistic regression analysis. Survival analysis was performed using the Cox regression hazard model and Kaplan–Meier methods. Sixty-nine patients underwent iPET-2 and 176 iPET-4. No association was found between the timing of iPET and iPET response status (P-value = 0.71). Two hundred and one patients (82%) had iPET-CMR and 44 (18%) iPET -nCMR. iPET was strongly associated with EoT response status: 194/201 (96 .5%) of iPET-CMR had a complete response at the EoT while only 21/44 (47.7%) of patients with iPET-nCMR presented a complete response at EoT (P-value |
نوع الوثيقة: | article |
وصف الملف: | electronic resource |
اللغة: | English |
تدمد: | 2045-2322 |
Relation: | https://doaj.org/toc/2045-2322 |
DOI: | 10.1038/s41598-022-22032-3 |
URL الوصول: | https://doaj.org/article/8d5741e4e47d4a00b2900ffee071be63 |
رقم الأكسشن: | edsdoj.8d5741e4e47d4a00b2900ffee071be63 |
قاعدة البيانات: | Directory of Open Access Journals |
تدمد: | 20452322 |
---|---|
DOI: | 10.1038/s41598-022-22032-3 |